
Please contact the doctor's office to verify that your insurance is accepted.
Dr. Kreniske conducts research on the clinical epidemiology of HIV-associated lung disease and tuberculosis in Tanzania. To date, Dr. Kreniske's work has included descriptive, qualitative, and quantitative research examining the social and biomedical factors which impact health in resource limited settings. Ultimately, Dr. Kreniske aims to predict and prevent chronic progressive cardiopulmonary disease among survivors of TB and people living with HIV. Dr. Kreniske's research is supported by the Stony Wold-Herbert Fund Fellowship. He attends clinically at the Weill Cornell Medical Center and the NYP-Lower Manhattan Hospital.
HIV status is linked to higher odds of persistent respiratory symptoms in Tanzania: a longitudinal analysis.
Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents.
HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing.